What is the single largest trend with respect to biologics manufacturing and where is the industry headed over the next 5 – 10 years? Find answers to these and other questions of importance to manufactures of biologics which emanated from a roundtable meeting of experts hosted by Pharmaceutical Outsourcing
A meeting of manufacturing experts from the biologics industry, including Vetter managing director, Peter Soelkner agree that the manufacturing of biologics is an area of growing importance due to therapeutic vaccines and high-value compounds. All signs for the biotech industry suggest significant growth over the next 5-10 years, particularly for those companies that address efficient manufacturing of complex and sensitive biologics. Learn more about these opportunities as well as primary areas of growth, the role of strategic partnering in relation to biologics manufacturing, and other important issues facing the industry at the Pharmaceutical Outsourcing roundtable of experts.
Biologics Manufacturing Roundtable
Peter Soelkner, Vetter managing director